Q-omics provides the consensus-scored RNU7-71P profile across patient tissues and cancer cell-line models. RNU7-71P expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, RNU7-71P is differentially expressed in 3, with the highest sampling consensus in THCA. Additionally, RNU7-71P RNA expression shows 10,976 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight KIRC, THCA, and KIRP as cancer lineages where RNU7-71P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU7-71P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU7-71P survival associations across molecular data types. RNU7-71P RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU7-71P RNA expression–survival associations across cancer types. High RNU7-71P expression shows unfavorable associations in MESO, CHOL and TGCT, but favorable associations in KIRC, UCS and ACC. The KIRC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for RNU7-71P RNA expression.
This table summarizes RNU7-71P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for RNU7-71P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU7-71P shows lower tumor expression in THCA and KICH and higher tumor expression in HNSC. The THCA box plot shows higher RNU7-71P RNA expression in normal versus tumor tissue (log2 FC = −1.162, t-test p < 0.001).
This table shows molecular features associated with RNU7-71P in patient tissues and cancer cell lines. In patient samples, RNU7-71P shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
